CoChat

The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study

Open access

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

AIMS: Recent European guidelines recommend to include high-density lipoprotein (HDL) cholesterol in risk assessment for primary prevention of cardiovascular disease (CVD), using a SCORE-based risk model (SCORE-HDL). We compared the predictive performance of SCORE-HDL with SCORE in an independent, contemporary, 'low-risk' European population, focusing on ability to identify those in need of intensified CVD prevention. METHODS AND RESULTS: Between 2003 and 2008, 46,092 individuals without CVD, diabetes, or statin use were enrolled in the Copenhagen General Population Study (CGPS). During a mean of 6.8 years of follow-up, 339 individuals died of CVD. In the SCORE target population (age 40-65; n = 30,824), fewer individuals were at baseline categorized as high risk (≥5% 10-year risk of fatal CVD) using SCORE-HDL compared with SCORE (10 vs. 17% in men, 1 vs. 3% in women). SCORE-HDL did not improve discrimination of future fatal CVD, compared with SCORE, but decreased the detection rate (sensitivity) of the 5% high-risk threshold from 42 to 26%, yielding a negative net reclassification index (NRI) of -12%. Importantly, using SCORE-HDL, the sensitivity was zero among women. Both SCORE and SCORE-HDL overestimated risk of fatal CVD. In well-calibrated models developed from the CGPS, HDL did not improve discrimination or NRI. Lowering the decision threshold from 5 to 1% led to progressive gain in NRI for both CVD mortality and morbidity. CONCLUSION: SCORE-HDL did not improve discrimination compared with SCORE, but deteriorated risk classification based on NRI. Future guidelines should consider lower decision thresholds and prioritize CVD morbidity and people above age 65.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehv251

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Proportion of individuals in the target population classified as high risk. The percentage of individuals classified as high risk (≥5% 10-year risk of fatal cardiovascular disease) was lower using SCORE-HDL (green) compared with SCORE (black). SCORE, Systematic COronary Risk Evaluation; HDL, high-density lipoprotein.
Figure 1 Proportion of individuals in the target population classified as high risk. The percentage of individuals classified as high risk (≥5% 10-year risk of fatal cardiovascular disease) was lower using SCORE-HDL (green) compared with SCORE (black). SCORE, Systematic COronary Risk Evaluation; HDL, high-density lipoprotein.CC BY-NC · PubMed Central
Figure 2 Calibration showing predicted vs. observed events. Both the original SCORE and the new SCORE-HDL models overestimated risk for fatal cardiovascular disease compared with Kaplan–Meier adjusted observed events. The straight line indicates perfect calibration (predicted events = observed events). Data represent men and women combined after 7 years of follow-up. SCORE, Systematic COronary Risk Evaluation; HDL, high-density lipoprotein.
Figure 2 Calibration showing predicted vs. observed events. Both the original SCORE and the new SCORE-HDL models overestimated risk for fatal cardiovascular disease compared with Kaplan–Meier adjusted observed events. The straight line indicates perfect calibration (predicted events = observed events). Data represent men and women combined after 7 years of follow-up. SCORE, Systematic COronary Risk Evaluation; HDL, high-density lipoprotein.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 64

Metadata

Authors
Mortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E.
Affiliations
  • Aarhus University Hospital (DK)
  • University of Copenhagen (DK)
Corresponding author
Nordestgaard, Børge G.
Venue
European Heart Journal
Published
2015-06-16
Volume
36
Issue
36
Pages
2446-2453
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W1910876008
Cited by
64
References
20
Citations by year
2024: 1 · 2023: 1 · 2022: 1 · 2021: 15 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 12 · 2016: 17 · 2015: 3
FWCI
11.75
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
Funders
Herlev Hospital, Copenhagen University Hospital, the Copenhagen County Foundation, and Aarhus University
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
SCORE risk model, HDL cholesterol, cardiovascular risk prediction, primary prevention, net reclassification improvement, risk classification, decision threshold, sex differences, cardiovascular mortality, cardiovascular morbidity, Copenhagen General Population Study
MeSH terms
Adult, Aged, Cardiovascular Diseases, Denmark, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Sensitivity and Specificity, Sex Distribution, Risk Assessment, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study. https://app.cochat.ai/papers/10.1093/eurheartj/ehv251
The paper
Mortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E. (2015). The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv251

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.